ask="0.73"
ask_size="1500"
average_daily_volume="3842640"
bid="0.67"
bid_size="3000"
book_value="0.17"
change="-0.05"
change_from_200_day_moving_average="0.34"
change_from_50_day_moving_average="0.25"
change_from_52_week_high="-0.06"
change_From_52_week_low="0.43"
change_in_percent="-6.92%"
close="0.71"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.30"
ebitda="-41.64M"
eps_estimate_current_year="-0.13"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.21"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.71"
high_52_weeks="0.77"
last_trade_date="3/14/2017"
last_trade_price="0.71"
last_trade_size="51575"
last_trade_time="4:00pm"
low="0.62"
low_52_weeks="0.28"
market_capitalization="182.57M"
moving_average_200_day="0.37"
moving_average_50_day="0.46"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.00"
open="0.69"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+89.89%"
percent_change_from_50_day_moving_average="+54.64%"
percent_change_from_52_week_high="-7.79%"
percent_change_from_52_week_low="+151.77%"
previous_close="0.76"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.54"
price_per_sales="3.60"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.26"
stock_exchange="NCM"
symbol="PPHM"
volume="6712071"
weeks_range_52="0.28 - 0.77"
